TEVA position history
The shares of Teva Pharmaceutical Industries (TEVA) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 403,996 shares, $3.9M, <0.01% of portfolio
- 2021 Q4: 304,792 shares, $2.4M, <0.01% of portfolio, Reduce −24.6%
- 2022 Q1: 300,012 shares, $2.8M, 0.01% of portfolio, Reduce −1.6%
- 2022 Q2: 232,518 shares, $2.1M, 0.01% of portfolio, Reduce −22.5%
- 2022 Q3: 335,468 shares, $2.7M, 0.02% of portfolio, Add +44.3%
- 2022 Q4: 259,163 shares, $2.4M, 0.02% of portfolio, Reduce −22.7%
- 2023 Q1: 211,778 shares, $1.9M, 0.01% of portfolio, Reduce −18.3%
- 2023 Q2: 237,923 shares, $1.8M, 0.01% of portfolio, Add +12.3%
- 2023 Q3: 254,810 shares, $2.6M, 0.02% of portfolio, Add +7.1%
- 2023 Q4: 222,806 shares, $2.3M, 0.01% of portfolio, Reduce −12.6%
- 2024 Q1: 192,136 shares, $2.7M, 0.02% of portfolio, Reduce −13.8%
- 2024 Q2: 169,420 shares, $2.8M, 0.02% of portfolio, Reduce −11.8%
- 2024 Q3: 123,865 shares, $2.2M, 0.02% of portfolio, Reduce −26.9%
- 2024 Q4: 100,443 shares, $2.2M, 0.02% of portfolio, Reduce −18.9%
- 2025 Q1: 90,253 shares, $1.4M, 0.01% of portfolio, Reduce −10.1%
- 2025 Q2: 120,874 shares, $2M, 0.01% of portfolio, Add +33.9%
- 2025 Q3: 118,721 shares, $2.4M, 0.01% of portfolio, Reduce −1.8%
- 2025 Q4: 105,131 shares, $3.3M, 0.02% of portfolio, Reduce −11.4%
- 2026 Q1: 68,279 shares, $2.1M, 0.02% of portfolio, Reduce −35.1%
- 2026 Q2: 68,653 shares, $2.3M, 0.02% of portfolio, Add +0.5%
- 2026 Q3: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|